0.00 14.29
Prev Close 0.00
Open 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Volume 57.38M
Exchange OTC
Shares Outstanding 2436.31B
Market Cap 1.71M
Div & Yield N.A. (N.A)

BioElectronics' Drug-free ActiPatch® Pain Therapy

Highlighted in UK's Express Newspaper on Dangers of Excessive Drug Use

BioElectronics President Interviewed By The

Discusses Bioelectronics Mitigation of Chronic Pain and Drug Use

BioElectronics Drug-free Chronic Pain Therapy Observation Study Results

61% Pain Reduction & Decreases Medication Use in 86% (including opioids)

BioElectronics Announces Oxford University Sponsored Study

ActiPatch® Therapy for Chronic Low Back Pain

BioElectronics Expands In The UK Market

Leading UK Retailer, Superdrug to market and sell ActiPatch® Pain Therapy

BioElectronics Supports Arthritis Campaign

Osteoarthritis is the Most Common Cause of Disability

BioElectronics Reports Stronger Second Quarter Results

Publishes Market Analysis of its Try & Tell Survey That Predicts Strong Ongoing Sales

BioElectronics Files FDA Premarket Notification For ActiPatch® Therapy

The Most Innovative Treatment for Chronic Pain

UpTick News Wire Radio Show Will Interview BioElectronics' CEO Andrew Whelan

Topics will Include UK Progress and New Clinical Publications

BioElectronics Expands Medical And OTC Distribution

Appoints Market Leader, Medikon, LTD as distributor in Turkey